Breast cancer trends in women in Cyprus: a population-based study between 2004-2017

Autor: A Quattrocchi, CA Demetriou, OA Cory, B Saad, C Constantinou, Y Marcou, A Demetriou, V Scoutellas, O Kolokotroni

Publikováno v: European Journal of Public Health. 32

Background In Cyprus, breast cancer (BC) is the first in incidence and second in mortality cancer in women. A national screening programme (NSP), targeting women 50-69 years, was introduced in 2007. The aim of this study is to provide a better unders

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7fecc2edb7a2f1446ce33ee3b2be1dc8
https://doi.org/10.1093/eurpub/ckac131.141

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

Autor: N Hamajima, K Hirose, K Tajima, T Rohan, CM Friedenreich, SM Gapstur, MM Gaudet, RJ Coates, JM Liff, E Kakouri, Y Marcou, SW Duffy, A Morabia, L Schuman, W Stewart, M Szklo, P Band, AJ Coldman, RP Gallagher, TG Hislop, P Yang, SR Cummings, J Hu, KC Johnson, Y Mao, P Chao, J Lissowska, K Canfell, PL Horn-Ross, LM Kolonel, AMY Nomura, T Bishop, D Palli, S De Sanjose, CA Gonzalez, N Lee, P Marchbanks, HW Ory, HB Peterson, P Wingo, K Ebeling, D Kunde, P Nishan, L Bergkvist, JL Hopper, F Sitas, S Franceschi, L Dal Maso, TH Chan, AH Eliassen, RM Tamimi, WC Willett, V Gajalakshmi, N Martin, T Pardthaisong, S Silpisornkosol, C Theetranont, B Boosiri, S Chutivongse, P Jimakorn, P Virutamasen, C Wongsrichanalai, A Neugut, R Santella, A Hadjisavvas, K Kyriacou, M Loizidou, CJ Baines, N Kreiger, AB Miller, C Wall, A Tjonneland T Jorgensen, C Stahlberg, A T0nnes Pedersen, E Negri, SE Hankinson, D Flesch-Janys, C La Vecchia, N Hakansson, I Heuch, HO Adami, E Weiderpass, A Ekbom, G Erlandsson, I Persson, C Magnusson, L Jones, K McPherson, A Neil, M Vessey, D Yeates, G Berry, J Cooper Booth, T Jelihovsky, R MacLennan, J Chang-Claude, R Kaaks, M Iwasaki, S Tsugane, GL Anderson, JR Daling, WB Hutchinson, CI Li, KE Malone, M Mandelson, PA Newcomb, EA Noonan, RM Ray, JL Stanford, MTC Tang, DB Thomas, NS Weiss, E White, A Izquierdo, P Viladiu, KM Egan, HR Cuevas, P Ontiveros, A Palet, SB Salazar, N Aristizabal, A Cuadros, L Tryggvadottir, EJ Olafsdottir, E Riboli, N Andrieu, A Bachelot, A Bremond, B Gairard, J Lansac, MG Le, L Piana, R Renaud, MC Boutron-Ruault, N Chabbert-Buffet, F Clavel-Chapelon, A Fournier, S Mesrine, F Levi, M Jones, AJ Swerdlow, A Wolk, K Kosmelj, M Primic-Zakelj, J Stare, G Torres-Mejia, I Romieu, P Boyle, F Lubin, B Modan, E Ron, Y Wax, M Ferraroni, E Marubini, EM Monninkhof, NC Onland-Moret, PHM Peeters, GD Friedman, RA Hiatt, M Touillaud, WL Beeson, G Fraser, J Peto, RL Hanson, MC Leske, MC Mahoney, PC Nasca, AO Varma, AL Weinstein, RA Goldbohm, PA van den Brandt, N Chantarakul, S Koetsawang, D Rachawat, MC Pike, M Gerber, S Richardson, C Segala, S Teitelbaum, D Gatei, P Kenya, A Kungu, JG Mati, LA Brinton, M Freedman, R Hoover, C Schairer, RG Ziegler, E Banks, R Spirtas, HP Lee, MA Rookus, FE van Leeuwen, JA Schoenberg, S Graff-Iversen, R Selmer, S Atkinson, I Barnes, V Beral, D Bull, T Gathani, A Goodill, J Green, C Hermon, T Key, K Pirie, G Reeves, K Shaw, TO Yang, R Collins, HC Pan, R Peto, R Ghiasvand, K Mabuchi, D Preston, SE McCann, P Hannaford, C Kay, JM Hampton, LJ Titus, A Trentham-Dietz, B Liu, YT Gao, F Jin, J-M Yuan, HY Wei, T Yun, C Zhiheng, PF Coogan, JR Palmer, L Rosenberg, EM John, Q-S Wang, M Kawai, Y Minami, I Tsuji, M Kumle, H Stalsberg, E Lund, EO Fourkala, I Jacobs, U Menon, A Ryan, L Hartman, H Olsson, K Katsouyanni, A Trichopoulou, A Tzonou, KA Baltzell, A Dabancens, L Martinez, R Molina, O Salas, L Rosero-Bixby, FE Alexander, K Anderson, AR Folsom, MD Gammon, BS Hulka, R Millikan, CED Chilvers, M McCredie, C Paul, DCG Skegg, GFS Spears, F Lumachi, TR Rebbeck, RA Apelo, J Baens, JR de la Cruz, B Javier, LB Lacaya, CA Ngelangel, J Cauley, for the Study of Osteoporotic Fractures, C Bain, F Schofield, V Siskind, L Bernstein, S Enger, RW Haile, A Paganini-Hill, G Ursin, AH Wu, MC Yu, M Ewertz, EA Clarke, XO Shu, W Zheng, M Gass, MJ O’Sullivan, A Kalache, TMM Farley, S Holck, O Meirik, A Fukao, X Zhou

Publikováno v: Lancet, 394(10204), 1159-1168. Elsevier Science

Background: Published findings on breast cancer risk associated with different types of menopausal hormone therapy (MHT) are inconsistent, with limited information on long-term effects. We bring together the epidemiological evidence, published and un

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::439d0f8027a6f9d2226fb0e42b5966f1
https://cris.maastrichtuniversity.nl/en/publications/88a75911-ca7a-43e6-91a1-ba6c24758e34

BRCA1 and BRCA2 mutation testing in Cyprus; a population based study

Autor: M A, Loizidou, A, Hadjisavvas, P, Pirpa, E, Spanou, T, Delikurt, G A, Tanteles, M, Daniel, P, Kountourakis, S, Malas, G, Ioannidis, I, Zouvani, E, Kakouri, D, Papamichael, Y, Marcou, V, Anastasiadou, K, Kyriacou

Publikováno v: Clinical genetics. 91(4)

This paper presents the largest study in Cyprus evaluating the frequency and distribution of BRCA1/2 mutations in a high risk patient cohort. Deleterious mutations in the BRCA1/2 genes were identified in 68 of the 527 patients tested (13%). It is of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3284494d799af0d20f46aa07ceb58382
https://pubmed.ncbi.nlm.nih.gov/27882536

The optimal management of brain metastases

Autor: N Ali, Y Marcou, PN Plowman

Publikováno v: International Journal of Clinical Practice. 54:209-211

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7dc2f760e1fd3750e535ace88273b853
https://doi.org/10.1111/j.1742-1241.2000.tb11886.x

What is the optimal therapy of brain metastases?

Autor: C. Lindquist, C. Adams, S. Retsas, Y. Marcou, Piers N. Plowman

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)). 13(2)

The conclusions of a symposium held in London in October 1999 and devoted to the optimal management of brain metastatic disease were: 1. Prognostic factors are: size and number of metastases (and the presence of mass effect); the status of the system

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17af6c67ba54b7d0254ecadf7c5a2a0c
https://pubmed.ncbi.nlm.nih.gov/11373869